Xebra Brands Ltd. Terminates Acquisition Plans, Continues U.S. CBD Expansion

Xebra Brands Ltd. ( (TSE:XBRA) ) has issued an update.

Xebra Brands Ltd. has decided to terminate its non-binding Letter of Intent to acquire BSK Holdings Inc. after a thorough review, but will continue its partnership with BSK to launch the ELEMENTS™ CBD product line in the U.S. market. The company also announced a delay in its annual filings due to management changes and liquidity constraints, resulting in a management cease trade order for certain insiders. Additionally, Xebra has secured a C$110,000 loan from a co-founder to support its working capital and corporate purposes.

Spark’s Take on TSE:XBRA Stock

According to Spark, TipRanks’ AI Analyst, TSE:XBRA is a Neutral.

Xebra Brands Ltd. scores 48.75, reflecting significant financial struggles, including high liabilities and negative cash flows. However, recent strategic corporate events, such as market expansions and regulatory achievements, provide potential growth opportunities. The technical analysis suggests upward momentum but warns of overbought conditions.

To see Spark’s full report on TSE:XBRA stock, click here.

More about Xebra Brands Ltd.

Xebra Brands Ltd. is a Canadian cannabis company with international reach, focusing on the development and commercialization of cannabis-derived wellness products. It is the first company authorized to import, cultivate, manufacture, and sell cannabis with less than 1% THC in Mexico and is expanding its ELEMENTS™ product line through strategic partnerships in North America.

Average Trading Volume: 128,892

Technical Sentiment Signal: Sell

Current Market Cap: C$2.26M

Learn more about XBRA stock on TipRanks’ Stock Analysis page.